Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Jubilant Pharmova LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:530019NSE Symbol: JUBLPHARMAP/E(TTM):0
ISIN Demat:INE700A01033Div & Yield %:0.46EPS(TTM):0
Book Value(Rs):140.8744507Market Cap ( Cr.):17282.46Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 15.9015.9015.9015.9315.9315.93
Reserves Total 2302.202358.602398.602423.141266.522591.37
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2318.102374.502414.502439.071282.452607.30
Secured Loans 213.40261.40222.5095.0095.00898.90
Unsecured Loans 122.80119.10123.1087.52408.711113.69
Total Debt336.20380.50345.60182.52503.712012.59
Other Liabilities28.0027.4023.4024.065.3466.85
Total Liabilities2682.302782.402783.502645.651791.504686.74
APPLICATION OF FUNDS :      
Gross Block 1025.10997.30947.40863.48148.932288.40
Less : Accumulated Depreciation 326.40286.00260.00226.9721.85423.68
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 698.70711.30687.40636.51127.081864.72
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress19.3037.0047.0035.260.3359.09
Producing Properties0.000.000.000.000.000.00
Investments 1657.001656.901656.601645.751645.981764.03
Current Assets, Loans & Advances      
Inventories 232.40250.90313.60323.180.00656.38
Sundry Debtors 206.30194.20188.50130.700.00425.45
Cash and Bank12.6036.1011.0022.5340.33257.73
Loans and Advances 32.9059.4065.7049.4025.92382.57
Total Current Assets484.20540.60578.80525.8166.251722.13
Less : Current Liabilities and Provisions      
Current Liabilities 206.30202.40213.70238.8432.94706.33
Provisions 21.007.1011.2011.0711.3029.02
Total Current Liabilities227.30209.50224.90249.9144.24735.35
Net Current Assets256.90331.10353.90275.8922.00986.78
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets128.20126.40128.6036.690.00245.78
Deferred Tax Liability116.60114.50111.601.358.86257.09
Net Deferred Tax11.6011.9017.0035.34-8.86-11.31
Other Assets38.8034.2021.6016.904.9623.42
Total Assets2682.302782.402783.502645.651791.494686.73
Contingent Liabilities66.1077.5070.3070.0768.85345.84